OncoMatch

OncoMatch/Clinical Trials/NCT04511078

Phase II Panitumumab-IRDye800 in Head & Neck Cancer

Is NCT04511078 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies Panitumumab-IRDye800 for head and neck cancer.

Phase 2RecruitingUniversity of Alabama at BirminghamNCT04511078Data as of Jun 2026

Treatment: Panitumumab-IRDye800The purpose of this study is to determine if panitumumab-IRDye800 is effective in identifying cancer, compared to surrounding normal tissue, and the further characterize the safety profile of this drug.

Check if I qualify

Extracted eligibility criteria

Treatments studied

Other

Panitumumab-IRDye800

Cancer type

Head and Neck Squamous Cell Carcinoma

Disease stage

Required: Stage ANY T STAGE

Diagnosis of any T stage, any subsite within the head and neck that are scheduled to undergo surgical resection

Prior therapy

Cannot have received: investigational drug

Lab requirements

Blood counts

Hemoglobin ≥ 9 gm/dL; Absolute Neutrophil Count ≥ 1500; White Blood Cell count > 3000/mm3; Platelet count ≥ 100,000/mm3

Kidney function

Serum creatinine ≤ 1.5 times upper reference range

Liver function

acceptable liver function

Have acceptable hematologic status, coagulation status, kidney function, and liver function including the following clinical results: Hemoglobin ≥ 9 gm/dL; Absolute Neutrophil Count ≥ 1500; White Blood Cell count > 3000/mm3; Platelet count ≥ 100,000/mm3; Serum creatinine ≤ 1.5 times upper reference range

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

  • University of Alabama at Birmingham · Birmingham, Alabama

Showing up to 5 US sites.

See all sites on ClinicalTrials.gov →

Frequently asked questions

Is NCT04511078 currently recruiting?

Yes, this trial is currently recruiting patients.

Are there prior therapy exclusions?

Yes. Prior investigational drug disqualifies patients from enrollment.

What disease stage is eligible?

Stage ANY T STAGE is required.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify